Invesco’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $445K | Buy |
68,507
+22,083
| +48% | +$144K | ﹤0.01% | 3202 |
|
|
2025
Q1 | $368K | Buy |
46,424
+13,636
| +42% | +$108K | ﹤0.01% | 3270 |
|
|
2024
Q4 | $415K | Buy |
32,788
+798
| +2% | +$10.1K | ﹤0.01% | 3300 |
|
|
2024
Q3 | $446K | Buy |
31,990
+766
| +2% | +$10.7K | ﹤0.01% | 3265 |
|
|
2024
Q2 | $430K | Sell |
31,224
-419
| -1% | -$5.77K | ﹤0.01% | 3325 |
|
|
2024
Q1 | $523K | Buy |
31,643
+285
| +0.9% | +$4.71K | ﹤0.01% | 3299 |
|
|
2023
Q4 | $458K | Buy |
31,358
+12,196
| +64% | +$178K | ﹤0.01% | 3263 |
|
|
2023
Q3 | $235K | Buy |
19,162
+3,068
| +19% | +$37.6K | ﹤0.01% | 3520 |
|
|
2023
Q2 | $192K | Buy |
+16,094
| New | +$192K | ﹤0.01% | 3608 |
|
|
2022
Q3 | – | Sell |
-97,024
| Closed | -$1.74M | – | 3975 |
|
|
2022
Q2 | $1.74M | Buy |
+97,024
| New | +$1.74M | ﹤0.01% | 2754 |
|